Recruitment Completed in Prospective Sleep Apnoea Study
(World News Science)

ASX / MEDIA RELEASE ResApp Completes Recruitment in Prospective Sleep Apnoea Study Brisbane, Australia, 2 October 2018 -- ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce that it has completed recruitment in its prospective, double-blind, in-laboratory sleep apnoea clinical study with 600 patients recruited. The company is working with Dr Philip Currie and Dr Ivan Ling of Cardio Respiratory Sleep (CRS) to...